Skip to main content
. 2014 Aug 20;7(1):53–58. doi: 10.1016/j.slsci.2014.07.022

Table 1.

Clinical characterization and treatment of children with narcolepsy.

Number, gender Age at first symptoms (years) Age at Ds (years)/Ds delay (months) Age at onset (years)
Nocturnal sleep disturbance HLA test Initial/posterior BMI Treatment after Ds
Sleepiness Cataplexy Hallucinations Sleep paralysis
1, F 7 9/24 7 11 17 No DQB1⁎06:02/DRB⁎15 P90–95/P90–95 M
2, F 9 10/8 9 9 9 Yes DQB1⁎06:02/DRB⁎15 P90–95/P95–97 M+V
3, M 8 8/4 8 8 9 Yes DQB1⁎06:02/DRB⁎15 P90–95/P97 M+V
4, M 6 8/14 6 No DQB1⁎06:02/DRB⁎15 P85–90/P75–85 M
5, M 10 11/9 10 11 Yes DQB1⁎06:02/DRB⁎15 P95–97/P>97 M+V
6, F 6 9/24 6 9 Yes DQB1⁎06:02/DRB⁎15 P75/P25–50 M
7, M 10 11/15 10 Yes DQB1⁎06:02 P85–90/P75–85 M
8, M 7 9/24 7 9 Yes DQB1⁎06:02/DRB⁎15 P75–85/P85 M+V
Total (median) 6–10 (8) 8–11 (9)/4–24(14) 6–10 (8) 8–11 (9) 9–17 (9)

Ds – diagnosis; BMI – Body Mass Index; M – Methylphenidate; V – Venlafaxine.